To investigate whether SILD modifies the inflammatory response to high-dose STZ-induced hyperglycemia, we analyzed CD11b+GR1+ and CD11b+GR1- myeloid cells, that are involved in tissue remodeling. Here, ITGAM is linked to Hyperglycemia.